Understand the source comparison
Peptides and Reishi Mushroom Synergy: Research Comparison
Small neuropeptides (Dihexa, P21) 4 hours minimum PepT1 receptor competition with β-glucan fragments Moderate. Timing prevents antagonism but no direct synergy Strict separation required; dose peptide first for peak absorption GH secretagogues (MK 677, Ipamore
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Small neuropeptides (Dihexa, P21)
- 4 hours minimum
- PepT1 receptor competition with β-glucan fragments
- Moderate. Timing prevents antagonism but no direct synergy
- Strict separation required; dose peptide first for peak absorption
- GH secretagogues (MK 677, Ipamorelin)
- 2–3 hours (injectable forms)
- Cytokine modulation may enhance GH pulse amplitude
- High. Reishi's IL-6 effects complement GHRH pathway
- Consider strategic pairing rather than strict avoidance
- Thymus peptides (Thymalin)
- 2 hours (shortened window)
- Overlapping T-cell proliferation pathways
- Very High. Additive immunomodulation without competitive inhibition
- Shorter separation captures synergy while preserving bioavailability
- CYP3A4-sensitive peptides (Tesofensine)
- 6 hours minimum
- Hepatic enzyme induction reduces peptide half-life
- Low. Antagonistic if overlapped
- Extended separation mandatory; reishi dosed after peptide clears first-pass
- Orally bioavailable BPC-157 analogs
- PepT1 competition + potential CYP interaction
- Moderate. Separation prevents loss but no documented synergy
- Standard protocol applies; no unique benefit from pairing